Today: 20 May 2026
C.H. Robinson stock steadies after AI scare — insiders step in as traders brace for Tuesday
15 February 2026
2 mins read

C.H. Robinson stock steadies after AI scare — insiders step in as traders brace for Tuesday

NEW YORK, Feb 14, 2026, 17:59 EST — Market closed.

  • C.H. Robinson rebounded 4.9% Friday, clawing back some ground after it was hit by a steep AI-driven selloff the previous day.
  • Filings revealed that executives stepped in with open-market share buys following Thursday’s drop.
  • The company put out its annual 10-K on Friday, calling attention to risks tied to technology and AI.

C.H. Robinson Worldwide Inc (CHRW.O) rebounded sharply Friday, the stock ending at $176.01, climbing $8.17. The gain followed a steep plunge the previous session that rattled freight and logistics names.

Shares tumbled after little-known AI outfit Algorhythm Holdings claimed its SemiCab platform can ramp up customers’ freight volumes by as much as 300% to 400%—no extra staff needed, according to the company. Algorhythm also touted better output per operator, taking aim at a sector where revenue often hinges on how many loads each worker can juggle. The firm’s pitch includes slashing “empty miles,” or the amount of time trucks spend on the road with no cargo. https://www.globenewswire.com/news-release…

Why this hits now: C.H. Robinson operates as an asset-light freight broker—it lines up shipments but doesn’t own the trucks. That setup can spook investors when there’s talk of software eating into margins. The timing? Right as a fresh wave of “AI fear” trades sweeps through multiple sectors, pulling down shares of firms that even tout their tech credentials.

The Russell 3000 Trucking Index dropped 6.6% Thursday, as C.H. Robinson tumbled nearly 15% by the close—after sinking as deep as 24% earlier, according to the Guardian. Landstar System finished down about 16%, while RXO was hit even harder, slumping more than 20%. “The level of paranoia is category 5,” Joseph Shaposhnik, a portfolio manager with Rainwater Equity, told the paper. https://www.theguardian.com/business/2026/…

C.H. Robinson on Friday filed its annual report, touting itself as “a leader in Lean” AI supply chains after posting $16.2 billion in total revenue for 2025. In the same filing, the company didn’t mince words about “technological disruption,” noting “accelerated adoption of automation and AI” across the industry, with competitors leveraging “AI-driven freight matching” to lower expenses. https://www.sec.gov/Archives/edgar/data/10…

SEC filings revealed a string of executive stock purchases following the recent dip. CEO David P. Bozeman picked up 1,223 shares for $163.345 apiece on Feb. 12. Over on the strategy side, Arun Rajan—Chief Strategy and Innovation Officer—snapped up 605 shares at $167.111. Michael D. Castagnetto logged a total buy of 594 shares at a weighted average of $168.24.

Barclays kept its Overweight rating in a research note out Thursday, calling the recent selloff “disproportionate” and positioning the company more as an “AI disrupter” than one at risk of being disrupted, Investing.com reported. https://www.investing.com/news/analyst-rat…

Still, the volatility points to a market chasing headlines over hard fundamentals. Should a new platform gain meaningful ground with major shippers—or if established players ramp up spending to hold onto their turf—brokers might see investors factor in tighter spreads. In its annual filing, C.H. Robinson also highlighted exposure to tech, cybersecurity, and the “usage of AI technologies” as risks.

U.S. equity markets are closed Monday for Presidents Day. Tuesday’s in focus now—will the rebound stick when trading picks up again? Eyes are also on transportation stocks to see if the “AI disruption” theme continues to ripple through. https://www.nasdaqtrader.com/trader.aspx?i…

Looking ahead, earnings loom as the big trigger. The next report should land near April 29. Investors are watching for signs those productivity improvements are holding up — plus, any hints on whether management treats the AI scare as just background chatter or something that’s actually moving the needle on pricing power.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Dow Jones at 49,500 after softer CPI — what to watch before Wall Street’s next session
Previous Story

Dow Jones at 49,500 after softer CPI — what to watch before Wall Street’s next session

Procter & Gamble stock price: PG shares slip as Italy ad probe and insider sale set up a key week
Next Story

Procter & Gamble stock price: PG shares slip as Italy ad probe and insider sale set up a key week

Go toTop